NAEUN HOSPITAL
No hidden fees – just official clinic prices. Pay at the clinic for Moyamoya disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Moyamoya disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Moyamoya disease treatment journey.
Dr. Han Yeongmin is a neurosurgeon (MD, PhD). He is Medical Director and Director of the Neurosurgery Center at Incheon St. Mary’s Hospital. He treats cerebrovascular disease and peripheral nerve disorders. He also specializes in brain tumors and skull base surgery. Conditions include stroke, cerebral hemorrhage, cerebral infarction, and moyamoya disease. He performs PEN, PNP, and SNB. He also offers microscopic and endoscopic discectomy, artificial disc replacement, MIS-TLIF/minimally invasive spinal fusion, and vertebroplasty.
He earned his MD and PhD from The Catholic University of Korea. He served as a visiting professor in cerebrovascular and skull base surgery at Barrow Neurological Institute (Phoenix, Arizona, USA). He also served at Harborview Medical Center, University of Washington (Seattle, USA).
His publications include co-authorship of Chapter 52 of the Textbook of Korean Cerebrovascular Surgery. He also co-authored Acoustic Neuroma Oncology. He is a full member of KNS, KSCVS, KSBS, KBTS, KNTS, KSNS, and KSPNS.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
South Korea is a leading hub for Moyamoya treatment due to regional high prevalence and surgical mastery. Local neurosurgeons perform vast numbers of revascularization procedures. Facilities like Severance Hospital hold Joint Commission International (JCI) accreditation. These centers provide specialized multidisciplinary care for pediatric and adult cases.
Bookimed Expert Insight: Korea ranks 3rd globally for medical requests in our system, showing its high demand. While Severance Hospital manages 1.6 million outpatients annually, specialists like Dr. Yang Seyeon focus specifically on Moyamoya revascularization. This combination of massive scale and niche expertise ensures patients receive highly refined surgical care.
Patient Consensus: Patients value how Korean teams treat Moyamoya as a routine condition rather than a rare case. They appreciate the clear explanations regarding surgery versus medical management and the efficient international coordination provided by larger Seoul centers.
Surgical revascularization is the primary treatment for Moyamoya disease in the Republic of Korea. Surgeons prioritize combined revascularization to restore cerebral blood flow and prevent strokes. This method integrates direct bypass with indirect synangiosis. Modern Korean facilities provide these specialized procedures for symptomatic patients.
Bookimed Expert Insight: High-volume centers like Severance Hospital manage over 1 million outpatients annually. This massive scale allows Korean neurosurgeons to see Moyamoya cases frequently. Specialists like Dr. Yang Seyeon focus on vascular conditions including carotid stenosis and aneurysms. Their experience in high-traffic facilities leads to highly refined surgical techniques for rare vascular diseases.
Patient Consensus: Patients note that early evaluation is vital before symptoms worsen. They emphasize choosing surgeons with high procedure volumes for direct bypass surgery.
Leading South Korean hospitals for Moyamoya surgery include Gangnam Severance Hospital, Severance Hospital, and Seoul National University Bundang Hospital. These JCI-accredited centers specialize in direct and indirect revascularization. They utilize advanced neuro-imaging to restore cerebral blood flow and prevent strokes in patients.
Bookimed Expert Insight: While prestige matters, look for specific leadership in neurosurgery departments. Dr. Yang Seyeon at Naeun Hospital illustrates this, having moved from leading neurosurgery at G-Sam to his current role. A department head's personal case volume often dictates surgical precision more than general hospital size.
Patient Consensus: Patients note that major Seoul tertiary hospitals are the primary hubs for successful treatment. They advise checking if your surgeon personally handles a high volume of bypass cases.
South Korean clinics prioritize MRI and MRA as primary non-invasive diagnostic tools for Moyamoya disease. Digital Subtraction Angiography (DSA) remains the gold standard for staging and surgical planning. Specialized centers also utilize SPECT or PET scans to evaluate cerebral blood flow and vascular reserve capacity.
Bookimed Expert Insight: While diagnostic protocols are rigorous, clinic selection significantly impacts specialized care. Multi-profile centers like Severance Hospital manage over 1.6 million outpatients annually with JCI accreditation. This high volume often ensures rapid access to complex imaging like SPECT, which is critical for pre-surgical blood flow mapping.
Patient Consensus: Patients note that doctors typically start with MRI and MRA before moving to DSA for surgery prep. They often emphasize that imaging protocols are very detailed and focused on mapping blood flow.
Revascularization surgery in South Korea yields stable neurological improvements within 6 months. Patients often achieve long-term hemodynamic stability over 5 years. Leading JCI-accredited centers in Seoul utilize combined direct and indirect bypass methods. These techniques maximize cerebral blood flow and prevent future strokes.
Bookimed Expert Insight: Data suggests selecting multidisciplinary university hospitals like Severance Hospital provides superior safety for Moyamoya patients. These institutions combine neurosurgery with specialized pediatric and cardiovascular units under one roof. This integrated approach is vital since Moyamoya often requires life-long monitoring of vascular health across different body systems.
Patient Consensus: Patients emphasize that while they feel neurologically stable quickly, physical stamina and fatigue take much longer to resolve. They advise others not to rush returning to school or work, as deep recovery often extends beyond the visible healing of the scalp incision.
South Korean neurosurgeons typically prescribe antiplatelet agents and blood pressure medications after Moyamoya surgery. Low-dose aspirin is the standard for long-term stroke prevention. Specialists at Joint Commission International-accredited facilities also utilize cilostazol. It effectively reduces mortality risks in Korean patient populations.
Bookimed Expert Insight: Korea ranks 3 in global medical requests on our platform. High-volume centers like Severance Hospital handle millions of outpatients. Their doctors often adjust antiplatelet duration based on specific bypass techniques. Combined procedures may require longer medication cycles than indirect revascularization alone.
Patient Consensus: Patients note that hospital care involves frequent imaging to adjust drug dosages. Many emphasize confirming the exact blood pressure range their surgeon expects post-discharge.
Surgical revascularisation is the primary treatment for Moyamoya disease in South Korea. Surgeons perform direct or indirect bypass procedures to restore blood flow to the brain. This intervention helps prevent strokes. It manages symptoms like transient ischaemic attacks in both children and adults.
Bookimed Expert Insight: South Korea holds the third-highest global rank in our database for specialised requests. This volume reflects the high domestic prevalence of the disease. Consequently, centres like Severance Hospital maintain massive patient volumes, treating 1.6 million outpatients annually. This deep clinical experience often leads to more refined surgical techniques for complex cerebrovascular cases.
Patient Consensus: Patients emphasise that surgery aims to prevent strokes rather than provide a total cure. Many report returning to normal life within a year after bypass surgery in South Korea.
Moyamoya disease surgery in South Korea is highly successful. Leading centres report over 80% good outcomes. They achieve 99.3% five-year survival for children and 92.9% for adults. Surgeons use revascularisation techniques. These procedures effectively reduce future stroke risks and stabilise neurological health.
Bookimed Expert Insight: South Korea is a global hub for Moyamoya. This is because the condition is more common there. Specialists like Dr Han Yeongmin at NAEUN Hospital have extensive training from top American institutes. Hospitals like Gangnam Severance were first in Asia to use robotic systems. This high case volume means Korean teams have refined bypass techniques. They achieve a level rarely seen in Australia.
Patient Consensus: Patients note that recovery can take months as brain perfusion improves. Most report that the first weeks are exhausting. However, they eventually return to normal activities like riding bikes and using both hands.
South Korean surgeons treat Moyamoya disease with revascularisation surgery. Techniques include direct STA-MCA bypass, indirect bypass, or combined methods. These procedures redirect blood to the brain. Major centres in Seoul and Incheon use JCI-accredited protocols. They perform thousands of neurosurgical operations annually.
Bookimed Expert Insight: South Korea is a global hub for Moyamoya because their specialists manage massive patient volumes. Dr Han Yeongmin at NAEUN HOSPITAL treats thousands of complex neurovascular cases yearly. Teams at Severance Hospital also manage high case volumes. This high volume means surgeons are experts at switching techniques mid-surgery. If vessel walls are too fragile for sutures, they shift from a direct to an indirect bypass.
Patient Consensus: Patients note that surgery aims to lower stroke risk rather than cure the condition. Many return to normal life within one year. They recommend confirming whether the surgeon prefers direct or combined techniques before travelling to Seoul.
Moyamoya surgery in South Korea is recommended promptly after diagnosis for symptomatic patients to prevent strokes. Specialist centres prioritise early intervention for children to avoid permanent neurological damage. Doctors advise surgery when imaging shows restricted blood flow. They also advise it if patients experience transient ischaemic attacks.
Bookimed Expert Insight: South Korea is a global hub for neurosurgery. Gangnam Severance Hospital performs 1,300 neurological operations annually. Experienced specialists like Dr Han Yeongmin at NAEUN Hospital often treat complex cerebrovascular cases. Patients should allow at least 14 days in South Korea. This covers pre-op scans, surgery, and a mandatory 7-day recovery period before flying.
Patient Consensus: Patients note that Moyamoya surgery is a time-sensitive decision rather than an elective one. Most recommend booking appointments at least 1 month in advance. This is because popular Seoul clinics often have significant waiting lists for specialist consultations.
South Korean hospitals provide specialised Moyamoya disease treatment for both children and adults. Specialised centres use revascularisation surgery to restore brain blood flow. Leading facilities such as Severance Hospital maintain high safety standards with JCI and KOIHA accreditations.
Bookimed Expert Insight: While adult cases are common, paediatric Moyamoya care in South Korea is exceptionally robust. Severance Hospital collaborates directly with the Children's Hospital of Philadelphia. This partnership gives paediatric patients international-standard protocols for complex revascularisation cases.
Patient Consensus: Patients note that recovery is a gradual process as new blood-flow pathways develop over several months. Many emphasise that South Korean hospitals require new diagnostic testing on-site. The surgical plan is confirmed only after this testing.
To manage symptoms and prevent strokes, Korean specialists prescribe cilostazol, aspirin, and clopidogrel. These drugs are supplementary. Surgical revascularisation remains the primary treatment. Specialists at JCI-accredited centres like Severance Hospital personalise prescriptions. They adjust them according to age and stroke risk.
Bookimed Expert Insight: South Korea is a global hub for cerebrovascular expertise. Gangnam Severance Hospital performs over 1,300 neurosurgeries annually. Doctors like Dr Han Yeongmin at NAEUN Hospital often bring insights from top US institutions. This high volume allows Korean teams to refine medication protocols. These protocols specifically support long-term bypass success.
Patient Consensus: Patients note that surgery is the main step in Korea. Still, daily low-dose aspirin and staying hydrated are vital lifelong habits. They often receive cholesterol or seizure medications temporarily for a smoother recovery after revascularisation.
South Korea provides screening for Moyamoya disease due to one of the highest global prevalence rates. Specialised centres use high-resolution MRI, digital subtraction angiography, and genetic RNF213 testing. Major Seoul facilities, such as JCI-accredited Severance Hospital, offer these diagnostic protocols. They help manage familial risks and adult haemorrhagic stroke.
Bookimed Expert Insight: South Korean neurosurgery hubs show immense specialisation. Centres like Gangnam Severance perform over 1,300 neurosurgical operations annually. Data shows specialists often hold dual international fellowships. For example, Dr Han Yeongmin trained at the Barrow Neurological Institute. This deep expertise means diagnostic accuracy is high for Moyamoya cases. Such cases may be misdiagnosed elsewhere as generic strokes.
Patient Consensus: Patients note that Moyamoya is difficult to spot without specific vascular imaging like MRA. They recommend that patients make sure their medical pathway includes both MRI and confirmatory catheter angiography in South Korea.